Scientists begin to reveal what it is about fragmented nightly sleep that leads to the fatty arterial plaque buildup that can result in fatal heart disease.
A study of electronic medical records from US Veterans Health Administration medical centers has found that hydroxychloroquine -- with or without azithromycin -- did not reduce the risk of ventilation or death and was associated with longer length of hospital stay. This analysis, published June 5 in the journal Med, is the first in the US to report data on hydroxychloroquine outcomes for COVID-19 from a nationwide integrated health system.
Clinicians can use this information to improve care with early interventions.
Women who have experienced childhood trauma become mothers earlier than those with a more stable childhood environment shows a new study conducted in collaboration between the University of Turku and the University of Helsinki in Finland. The trauma children experience form living in war zones, natural disasters or perhaps even epidemics can have unexpected effects that resurface later in their lives.
University of Texas Health Science Center at San Antonio researchers confirmed the role of a certain protein, Nox4, in the development of high-grade kidney cancer. The researchers also showed that a higher level of the protein can be used as a marker to predict in humans which tumors will develop treatment resistance and progress more rapidly.
Women's risk of falling ill with cardiovascular disease, and dying from it, is lower than that of men of the same age, irrespective of where in the world they live. This is shown by a study of, in total, more than 160,000 men and women in 27 countries. Scientists at the University of Gothenburg, Sweden, are among those presenting the results.
A new American Cancer Society study puts a price tag on racial disparities in cancer mortality, finding that $3.2 billion in lost earnings would have been avoided in 2015 if non-Hispanic (NH) blacks had equal years of life lost from cancer deaths and earning rates as NH whites.
A new BJS (British Journal of Surgery) study indicates that breast cancer surgery is safe for patients who are older than 70 years of age, but age can influence the decision to undergo surgery.
Researchers at Tulane University School of Medicine identified a gene that causes an aggressive form of breast cancer to rapidly grow. More importantly, they have also discovered a way to "turn it off" and inhibit cancer from occurring. The animal study results have been so compelling that the team is now working on FDA approval to begin clinical trials and has published details in the journal Scientific Reports.
New research conducted by the University of Liverpool and AKL Research and Development Ltd (AKLRD), published in Inflammopharmacology, highlights the potential benefits of a new drug treatment on the human body's immune response in inflammation.